The latest myeloma treatment advances from ASCO 2023


The 2023 American Society of Clinical Oncology (ASCO) annual meeting was held from June 2 to 6 in Chicago! Clinicians and researchers gathered to present and discuss several updates in multiple myeloma relating to: Chimeric antigen receptor (CAR) T-cell therapies, Bispecific antibodies (also known as T-cell engagers) in combination or as monotherapy, Treatment for newly diagnosed disease, and Maintenance therapy. Let us break down the key findings for you…


Related Videos
Kristie L. Kahl and Mary Derome
Kristie L. Kahl and Amy Pierre
Kristie L. Kahl and Dr. Nina Shah
Kristie L. Kahl and Dr. Hearn J. Cho
Kristie L. Kahl and Dr. Irene Ghobrial